



home















































































our focus



          back
        



          our focus
        


community engagement


understanding brain diseases


neurology


alzheimer's disease


lennox-gastaut syndrome


migraine


parkinson's disease




psychiatry


alcohol use disorder


bipolar disorder


borderline personality disorder


depression


generalized anxiety disorder


post-traumatic stress disorder


schizophrenia




report a side effect




our science



          back
        



          our science
        


research and development


our value chain




products


pipeline


medical education


progress in mind resource center


lundbeck institute




clinical trials


clinical trial diversity


study synopses




clinical data sharing


publications




stories


sustainability



          back
        



          sustainability
        


access to brain health


climate action


donations and grants


health and safety at work


materials use and waste


responsible business conduct


suppliers and third-parties


transparent interactions




about us



          back
        



          about us
        


our commitment


diversity, equity and inclusion


our position on brain health


our position on patient centricity




this is lundbeck


at a glance


organization and ownership


the lundbeck foundation


our history




our leadership


executive management


board of directors




corporate governance


board tasks


remuneration


risk management










careers



          back
        



          careers
        


life at lundbeck


our culture and people


being diverse and inclusive


employee development




your job


job opportunities


career areas


recruitment process


unsolicited applications




early career programs 


students






investors



          back
        



          investors
        


releases


release subscription




financials


reports and presentations


annual reporting 2024




events


financial calendar


general meeting




investor portal


the share


share data


shareholders and dividends


analyst coverage


new share structure




debt




partnering



          back
        



          partnering
        


partnership initiatives 


lighthouse life science


lundbeck biotech incubator


head-wind®




lundbeck cdm




press







contact









other sites (global)



        back
      


global



        back
      


global site




africa



        back
      


south africa




americas



        back
      


argentina


brazil


canada


chile


colombia


mexico


panama


peru


united states




asia



        back
      


china


israel


japan


korea


singapore


turkey




europe



        back
      


austria


belgium


bulgaria


czech republic


denmark


estonia


finland


france


germany


greece


ireland


italy


netherlands


norway


poland


portugal


russia


slovakia


slovenia


spain


sweden


switzerland


united kingdom




oceania



        back
      


australia/new zealand




other sites



        back
      


drughunters


elaiapharm


lundbeck cdm


lundbeck gbs krakow


brain battle












































  celebrate lundbeck's women in science with us




  at lundbeck, we’re proud to celebrate the incredible women in science shaping the future – no matter if it’s international day of women and girls in science (11 february each year) or any other day of the year.




          read full story
     





























  this is lundbeck



we are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization. 





          about us
     
















with more than 70 years of neuroscience expertise, lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.





          our science
     

















  latest news



    




12 february, 2025
press release

lundbeck’s potential treatment amlenetug for multiple system atrophy receives fast track designation from the fda



05 february, 2025
corporate release

transactions with shares and linked securities in lundbeck made by executives and their closely associated parties



05 february, 2025
corporate release

lundbeck annual report 2024





          see all news
     










come join us in making a difference to patients worldwide.





          job opportunities
     













explore the latest financial developments at lundbeck.





          investors
     


































  a better life for people with brain diseases




at lundbeck, we see patients as people and are committed to support the person and community behind the disease. 





          our focus
     































  our sustainability strategy




through our sustainability strategy, we mitigate business risks, reduce negative impacts, and address societal challenges where possible. we remain committed to un global compact principles, and contribute to seven of the 17 un sustainable development goals.




          read more
     































  partnering




the complexity of brain diseases requires a concerted effort. we are committed to develop new and better treatment options from innovations born in house or externally.




          read more
     

































   mara formentini on working at lundbeck 



    


  bringing your whole self to work and its rewards
 







          read more
     





          see all stories
     


















  lundbeck at a glance


























h. lundbeck a/s

        ottiliavej 9 
         
         
        2500 valby
        denmark
      



headquarters



+45 3630 1311


info@lundbeck.com





links




                report a side effect
              



                compliance hotline
              



                terms of use
              



                contact us
              



                social media principles
              



                  cookie settings
              






connect with us



























        privacy policy
      







copyright© 2025
        h. lundbeck a/s







